Key result
The COVID-19 pandemic shows no association with Emergency Laparotomy Pathway performance or efficiency outcomes.
Why the study?
Emergency laparotomy is associated with high post-operative morbidity, and the study aimed to evaluate the sustainability of a peri-operative pathway for emergency laparotomy during the COVID-19 pandemic.
Does the Emergency Laparotomy Pathway (ELAP) maintain efficiency and clinical outcomes during the COVID-19 pandemic in patients undergoing emergency laparotomy?
Observational (n=564)
No
Does the Emergency Laparotomy Pathway (ELAP) maintain efficiency and clinical outcomes during the COVID-19 pandemic in patients undergoing emergency laparotomy?
The performance of a transdisciplinary peri-operative pathway for emergency laparotomy was sustained despite the major healthcare disruptions caused by the COVID-19 pandemic.
Supports resilience of emergency laparotomy pathways during crises; observational data leaves generalizability open for prospective study.
BACKGROUND: Emergency laparotomy (EL) is associated with high post-operative morbidity. This study aims to evaluate the sustainability of our peri-operative pathway for EL (Emergency Laparotomy Pathway (ELAP)) during the COVID-19 pandemic. METHODS: This is a single-center retrospective study on patients who underwent EL following ELAP implementation from Jan 2019-Dec 2022. Exclusion criteria were EL for trauma or vascular surgery. The cohort was divided based on the COVID-19 pandemic (COVID was defined from 7 Feb 2020-25 Apr 2022). Cumulative sum (CUSUM) analysis was used to assess the chronologic performance of ELAP. Our primary outcomes were efficiency outcomes (time to surgery, presence of senior surgeon/anaesthetist in theatre and post-operative geriatric review). Our secondary outcomes were post-operative complications, major morbidity, and 30-day mortality. RESULTS: There were 564 patients (30.5% pre-COVID, 52.1% COVID, 17.4% post-COVID). The median age was 66.0 years, and 57.6% had ASA score ≥ 3. The commonest indication for EL was intestinal obstruction (56.9%). Overall major morbidity was 14.0%, and 30-day mortality was 2.8%. CUSUM analysis showed two phases-exploration phase (Case 1-158) and proficiency phase (Case 159-564); an inflection point was noted following the exploration phase, which showed a more sustained performance in achieving post-operative geriatric review and absence of post-operative complications or major morbidity. There was no observed relationship between COVID-19 and the performance of ELAP in both efficiency and clinical outcomes. CONCLUSION: The good performance of ELAP was sustained at 4 years following its initial implementation despite the COVID-19 pandemic, which resulted in major disruptions to healthcare delivery.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2025) conducted an observational in Emergency laparotomy (n=564). COVID-19 pandemic vs. Pre-COVID and post-COVID periods was evaluated on Efficiency outcomes (time to surgery, presence of senior surgeon/anaesthetist in theatre and post-operative geriatric review). The COVID-19 pandemic had no observed relationship with the performance of the Emergency Laparotomy Pathway, which had an overall major morbidity of 14.0% and 30-day mortality of 2.8%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: